Towards Healthcare
U.S. 503B Compounding Pharmacies Market Grows at 7.63% CAGR by 2034

U.S. 503B Compounding Pharmacies Market

According to forecasts, the global U.S. 503B compounding pharmacies market will grow from USD 1.16 billion in 2024 to USD 2.42 billion by 2034, with an expected CAGR of 7.63%. The need for 503B compounding pharmacies is growing because of the growing focus on patient safety and adherence to regulations.

  • Insight Code: 5386
  • No. of Pages: 150+
  • Format: PDF/PPT/Excel
  • Published: May 2025
  • Report Covered: [Revenue + Volume]
  • Historical Year: 2021-2022
  • Base Year: 2023
  • Estimated Years: 2024-2033

About The Author

Shivani Zoting is a dedicated research analyst specializing in the healthcare industry. With a strong academic foundation, a B.Sc. in Biotechnology and an MBA in Pharmabiotechnology, she brings a unique blend of scientific understanding and market strategy to her research.

Shivani contributes to Towards Healthcare and plays an active role at Precedence Research, where she focuses on delivering in-depth market intelligence, competitive analysis, and trend forecasting across pharmaceuticals, medical devices, digital health, and healthcare services. Her insights support healthcare companies, investors, and policymakers in making data-backed decisions in a highly regulated and rapidly evolving sector.

Additionally, Shivani collaborates with Statifacts, further expanding her healthcare domain reach by engaging in diverse projects across global markets. Her strength lies in transforming complex clinical and commercial data into strategic narratives that help stakeholders navigate the future of healthcare.

FAQ's

The U.S. 503B compounding pharmacies market size was estimated at US$ 1.08 billion in 2023 and is projected to grow US$ 2.25 billion by 2033.

7.63% is the growth rate of the U.S. 503B compounding pharmacies industry.